Mouse Tumor Biology Database (MTB)
MTB Home   Help
Search for Help
 
in these sections
Search Forms
Tumor
Strain
Genetics
Pathology Images
Reference
Advanced
Search MTB Using Human Genes
Gene Expression Data Sets

Additional Resources
new PDX Like Me
PDX Finder
PDX Model Search
Faceted Tumor Search
Dynamic Tumor Frequency Grid
Other Cancer Websites
Immunohistochemistry
Lymphoma Pathology

Mouse Genome Informatics
The Jackson Laboratory
Citing These Resources
Warranty Disclaimer
& Copyright Notice

Send Questions and
Comments to User Support.

Last Database Update
2019-11-17
MTB 3.0
 
HelpHelp and Documentation Tumor Summary  

Tumor Name Leukocyte
lymphoma
Treatment Type Virus
Tumor Synonyms nonthymic lymphoma (non-thymic lymphoma)  •  lymphoma
 
Strain
BALB/c
Strain Type:
inbred
General Note:
Substrain not specified.
Strain Synonyms Bagg  •  B alb C  •  C  •  Bagg Albino  •  BALB  •  Bagg albino  •  balb/c  •  C strain  •  WT  •  BALB/c (WT)  •  BALB/C  •  Cb

MTB ID Organ Affected Treatment Type
Agents
Strain Sex Reproductive Status Infection Status Frequency Age Of
Onset
Age Of
Detection
Additional
Information
Reference
MTB:7467 Leukocyte Virus
A-MuLV - Abelson murine leukemia virus (A-MuLV-P160)
Unspecified reproductive status not specified A-MuLV+ 100%
(14 of 14 mice)
20 days post injection   Treatment Note J:24306
MTB:7468 Leukocyte Virus
MoMuLV - Moloney murine leukemia virus (M-MuLV) (MMLV)
Unspecified reproductive status not specified MoMuLV+ 93%
(39 of 42 mice)
92 days post injection   Treatment Note J:24306
MTB:7469 Leukocyte Virus
MoMuLV - Moloney murine leukemia virus (M-MuLV) (MMLV)
Unspecified reproductive status not specified MoMuLV+ 0%
(0 of 20 mice)
  120 days post injection Treatment Note J:24306
MTB:9776 Leukocyte Virus
A-MuLV - Abelson murine leukemia virus (A-MuLV-P160)
Unspecified reproductive status not specified A-MuLV+ 100%
(20 of 20 mice)
20 days post injection   Treatment Note J:24306
MTB:9777 Leukocyte Virus
A-MuLV - Abelson murine leukemia virus (A-MuLV-P160)
Unspecified reproductive status not specified A-MuLV+ 95%
(114 of 120 mice)
30 days post injection   Treatment Note J:24306